These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

525 related items for PubMed ID: 21353101

  • 1. Contemporary pharmacologic treatments for spasticity of the upper limb after stroke: a systematic review.
    Olvey EL, Armstrong EP, Grizzle AJ.
    Clin Ther; 2010 Dec; 32(14):2282-303. PubMed ID: 21353101
    [Abstract] [Full Text] [Related]

  • 2. Botulinum toxin type B in upper-limb poststroke spasticity: a double-blind, placebo-controlled trial.
    Brashear A, McAfee AL, Kuhn ER, Fyffe J.
    Arch Phys Med Rehabil; 2004 May; 85(5):705-9. PubMed ID: 15129392
    [Abstract] [Full Text] [Related]

  • 3. Multidisciplinary rehabilitation following botulinum toxin and other focal intramuscular treatment for post-stroke spasticity.
    Demetrios M, Khan F, Turner-Stokes L, Brand C, McSweeney S.
    Cochrane Database Syst Rev; 2013 Jun 05; (6):CD009689. PubMed ID: 23740539
    [Abstract] [Full Text] [Related]

  • 4. Botulinum toxin type A for the treatment of the upper limb spasticity after stroke: a meta-analysis.
    Cardoso E, Rodrigues B, Lucena R, Oliveira IR, Pedreira G, Melo A.
    Arq Neuropsiquiatr; 2005 Mar 05; 63(1):30-3. PubMed ID: 15830061
    [Abstract] [Full Text] [Related]

  • 5. What's the "catch" in upper-limb post-stroke spasticity: expanding the role of botulinum toxin applications.
    Rosales RL, Kanovsky P, Fernandez HH.
    Parkinsonism Relat Disord; 2011 Nov 05; 17 Suppl 1():S3-10. PubMed ID: 21999894
    [Abstract] [Full Text] [Related]

  • 6. Repeated treatments with botulinum toxin type a produce sustained decreases in the limitations associated with focal upper-limb poststroke spasticity for caregivers and patients.
    Elovic EP, Brashear A, Kaelin D, Liu J, Millis SR, Barron R, Turkel C.
    Arch Phys Med Rehabil; 2008 May 05; 89(5):799-806. PubMed ID: 18452724
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after stroke.
    Jahangir AW, Tan HJ, Norlinah MI, Nafisah WY, Ramesh S, Hamidon BB, Raymond AA.
    Med J Malaysia; 2007 Oct 05; 62(4):319-22. PubMed ID: 18551937
    [Abstract] [Full Text] [Related]

  • 9. Botulinum Toxin Type A for Upper Limb Spasticity in Poststroke Patients: A Meta-analysis of Randomized Controlled Trials.
    Jia S, Liu Y, Shen L, Liang X, Xu X, Wei Y.
    J Stroke Cerebrovasc Dis; 2020 Jun 05; 29(6):104682. PubMed ID: 32305277
    [Abstract] [Full Text] [Related]

  • 10. Effectiveness of Botulinum Toxin for Lower Limbs Spasticity after Stroke: A Systematic Review and Meta-Analysis.
    Wu T, Li JH, Song HX, Dong Y.
    Top Stroke Rehabil; 2016 Jun 05; 23(3):217-23. PubMed ID: 27077980
    [Abstract] [Full Text] [Related]

  • 11. Treatment of upper extremity spasticity in stroke patients by focal neuronal or neuromuscular blockade: a systematic review of the literature.
    van Kuijk AA, Geurts AC, Bevaart BJ, van Limbeek J.
    J Rehabil Med; 2002 Mar 05; 34(2):51-61. PubMed ID: 12019580
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Botulinum toxin in poststroke spasticity.
    Ozcakir S, Sivrioglu K.
    Clin Med Res; 2007 Jun 05; 5(2):132-8. PubMed ID: 17607049
    [Abstract] [Full Text] [Related]

  • 15. Approach to the treatment of limb disorders with botulinum toxin A. Experience with 187 patients.
    Pullman SL, Greene P, Fahn S, Pedersen SF.
    Arch Neurol; 1996 Jul 05; 53(7):617-24. PubMed ID: 8929169
    [Abstract] [Full Text] [Related]

  • 16. Botulinum toxin treatment of adult spasticity : a benefit-risk assessment.
    Sheean G.
    Drug Saf; 2006 Jul 05; 29(1):31-48. PubMed ID: 16454533
    [Abstract] [Full Text] [Related]

  • 17. Pooled analysis of the safety of botulinum toxin type A in the treatment of poststroke spasticity.
    Turkel CC, Bowen B, Liu J, Brin MF.
    Arch Phys Med Rehabil; 2006 Jun 05; 87(6):786-92. PubMed ID: 16731213
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and safety of higher doses of botulinum toxin type A NT 201 free from complexing proteins in the upper and lower limb spasticity after stroke.
    Santamato A, Panza F, Ranieri M, Frisardi V, Micello MF, Filoni S, Fortunato F, Intiso D, Basciani M, Logroscino G, Fiore P.
    J Neural Transm (Vienna); 2013 Mar 05; 120(3):469-76. PubMed ID: 22955957
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.